Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.
The week at Retraction Watch featured:
- Readers puzzle over marketing journal’s failures to retract
- Doing the right thing: Co-authors of researcher who covered up data fakery retract paper
- Journal retracts more articles for being “unethical, scientifically flawed, and based on racist ideas and agenda”
- Second time’s the charm: The author who requested a retraction twice
- Biotech’s data supporting Alzheimer’s trials under scrutiny
- Guest editor says journal will retract dozens of inappropriate papers after his email was hacked
Our list of retracted or withdrawn COVID-19 papers is up to 151.
Here’s what was happening elsewhere (some of these items may be paywalled, metered access, or require free registration to read):
- “Interviews with academic leaders almost uniformly referred to critically important factors that were considered to be more important in the hiring process than funding or publishing in high-profile journals.”
- “Politicians vying to succeed Angela Merkel…face a new threat as the election draws nearer: scrutiny by plagiarism hunters.”
- “Controls on ‘gain of function’ experiments with supercharged pathogens have been undercut despite concerns about lab leaks.”
- “The replication crisis fueled the open-science movement, which doesn’t mean that plenty of lousy science doesn’t still slip past peer review — just read Retraction Watch if you want evidence of that — but it does mean that studies that once would have generated applause now don’t pass muster.”
- “While an all-round manuscript check could make the lives of researchers easier, once they have finalised their paper, the question remains: Is the science accurate?”
- “Excel autocorrect errors still plague genetic research, raising concerns over scientific rigour.”
- “Leading light of research replicability Daniel Lakens says ‘uncomfortable questions’ and tough choices are required to restore trust in science.”
- “What role should non-academics have in evaluating the potential impact of new research projects?”
- “Best Practices and Innovative Approaches to Peer Review in Africa.”
- “What should you do when you get a result that seems wrong, but you can’t find any problems in the underlying data or calculations?”
- “Researchers around the world have been pressured by government agencies to delay, alter, or not publish the findings of trials that investigate public health interventions, a small study has reported.”
- “WHO Covid database has many ‘dodgy journals’, 70 papers are by Indians.”
- “Scientists Correct Study That Limited Some Female Runners.” And a take from Roger Pielke, Jr.
- “Penn Medicine apologizes for” dermatologist Albert Kligman, a “notorious doctor who conducted experiments on Holmesburg Prison inmates.”
- “Pandemic upends norms around peer-reviewed studies.”
- “‘China’s Dr Fauci’, Zhang Wenhong, cleared of thesis plagiarism accusations.”
- “Analysis suggests highly cited [COVID-19] papers could double [impact factors] JIFs of some general medical journals.”
- “Scientific fraud vs. art forgery (or, why are so many scientific frauds so easy to detect?)”
- “The U.S. Is Getting a Crash Course in Scientific Uncertainty.”
- “Australian Research Council under pressure after funding rule angers academic community.”
- “What to do if you’re asked to remove a citation to a preprint.” A guide from ASAPbio.
- “Poll results: here’s what (some) ecologists think about retracting old and superseded papers.”
- “Also, the temporal evolution of the team size reveals that teams smaller in size have more retractions.”
- “I meant to say the spring of 2022,” Fauci told CNN. “I misspoke. My bad.”
Like Retraction Watch? You can make a one-time tax-deductible contribution or a monthly tax-deductible donation to support our work, follow us on Twitter, like us on Facebook, add us to your RSS reader, or subscribe to our daily digest. If you find a retraction that’s not in our database, you can let us know here. For comments or feedback, email us at [email protected].
If your results seem wrong, you should find a colleague or a coauthor who can start from scratch looking at your data and calculations. They may be able to find a problem, although this doesn’t always work.
In terms of ‘funding’ effects, in my experience in the US government, there is lots of subtle and not so subtle pressure to get publications by government employees to toe the party line – changing words, adding additional material, trying to weaken inconvenient findings and get them sent to a lesser journal, and so forth.
Ref: “Hidden data: Public health research is at risk from suppression by governments, study finds.” – this study is now circulating amongst the anti-vax and COVID-conspiracy crowds as “proof” of government and big pharma suppression of COVID statistics and the effectiveness of anti-parasitic drugs such as Ivermectin and HCQ. Unintended consequences.
What a dubious headline by the NYT re ‘female’ runners and mentioning Caster Semenya right after.
Semenya is a male with 5AR2D, he must be male since the condition is male limited.
https://www.theguardian.com/sport/2019/jun/18/caster-semenya-iaaf-athletics-guinea-pig